• 92
  • 13
  • 收藏

OCGN Stock Pops on Key FDA News. Here’s What to Know.

InvestorPlace2021-12-10

Biopharmaceutical company Ocugen(NASDAQ:OCGN) announced today that the U.S. Food and Drug Administration (FDA) approved the company’s Investigational New Drug (IND) application for a human clinical ...

网页链接

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论13

  • CHoe
    ·2021-12-15
    Why
    回复
    举报
  • Dorcasnoobie
    ·2021-12-10
    [财迷] 
    回复
    举报
  • Lichiun
    ·2021-12-10
    Like please, thank you!
    回复
    举报
    收起
    • Lichiun
      Like
      2021-12-10
      回复
      举报
    • JeremyKok
      hi. please like and comment back. thank you.
      2021-12-10
      回复
      举报
    • Lichiun
      Like
      2021-12-10
      回复
      举报
  • Albaakbert
    ·2021-12-10
    Hock hock
    回复
    举报
  • HOCK
    ·2021-12-10
    No escape when they manipulate ETFs in their favor. Just HODL and it will pop.
    回复
    举报
  • JCinvest
    ·2021-12-10
    Yeah
    回复
    举报
  • MHh
    ·2021-12-10
    Still early days…
    回复
    举报
    收起
    • RS142
      will it shoot up??
      2021-12-10
      回复
      举报
    • MHh
      Dont know. it’s very early in the trial phase. If it passes then will shoot up. If it fails then likely will drop. It’s like gambling
      2021-12-10
      回复
      举报
  • 財神發
    ·2021-12-10
    Like pls 
    回复
    举报
    收起
    • JeremyKok
      hi. please like and comment back. thank you.
      2021-12-10
      回复
      举报
    • Lichiun
      Like
      2021-12-10
      回复
      举报
  • kingcrayon
    ·2021-12-10
    “Pops” it’s half a percent up AH 😂😂
    回复
    举报
  • JJSLIN
    ·2021-12-10
    🚀🚀🚀
    回复
    举报
  • Peem
    ·2021-12-10
    Ok
    回复
    举报
  • Choonpoh
    ·2021-12-10
    666
    回复
    举报
  • RobinChanKH
    ·2021-12-10
    Up
    回复
    举报
    收起
    • Peem
      yeh
      2021-12-10
      回复
      举报
 
 
 
 

热议股票

 
 
 
 
 

7x24